InsidersTradesSigma
Total declarations
Company
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Discover the full record of transactions filed by Session R.A. II. Director active across 1 company, notably Taysha Gene Therapies, Inc.. In total, 2 filings have been published. Split: 2 buys · 0 sell. Total volume traded: €356k. Activity tracked since 23 November 2021. The latest transaction was filed on 23 November 2021 (Acquisition). Regulator: SEC (Form 4). The full history is openly available.
Declarations2 total
16,510 shares@ US$12.120.010% mcap50.0% of flowCommon StockSEC:0001209191-21-068510:0
Ideal exit: 20 Aug 2022 (T+270)
16,510 shares@ US$12.12100.0% of flowCommon StockSEC:0001209191-21-068510
Ideal exit: 20 Aug 2022 (T+270)
2 of 2 declarations
